163 related articles for article (PubMed ID: 19415535)
1. 5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels.
Salepci T; Seker M; Uyarel H; Gumus M; Bilici A; Ustaalioğlu BB; Oztürk A; Sonmez B; Orcun A; Ozates M; Irmak R; Yaylaci M
Med Oncol; 2010 Jun; 27(2):416-20. PubMed ID: 19415535
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil induces arterial vasocontractions.
Südhoff T; Enderle MD; Pahlke M; Petz C; Teschendorf C; Graeven U; Schmiegel W
Ann Oncol; 2004 Apr; 15(4):661-4. PubMed ID: 15033676
[TBL] [Abstract][Full Text] [Related]
3. Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients.
Seker M; Isen HC; Çevirme N; Aydın S; Bilici A; Bulut H; Yasin AI; Coban E; Demir T; Aliyev A; Kocyigit A; Turk HM
Oncol Res Treat; 2018; 41(9):545-549. PubMed ID: 30121640
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
5. Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Saris JJ; van Dijk MA; Kroon I; Schalekamp MA; Danser AH
Hypertension; 2000 Mar; 35(3):764-8. PubMed ID: 10720592
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
7. Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion.
Ceyhan C; Meydan N; Barutca S; Tekten T; Onbasili AO; Ozturk B; Unal S; Bayrak I
J Clin Pharm Ther; 2004 Jun; 29(3):267-71. PubMed ID: 15153089
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
[TBL] [Abstract][Full Text] [Related]
9. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.
Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ
Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765
[TBL] [Abstract][Full Text] [Related]
10. Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
André T; Colin P; Louvet C; Gamelin E; Bouche O; Achille E; Colbert N; Boaziz C; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Billiau V; Buyse M; Gramont A;
Semin Oncol; 2001 Feb; 28(1 Suppl 1):35-40. PubMed ID: 11273588
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.
Polk A; Vistisen K; Vaage-Nilsen M; Nielsen DL
BMC Pharmacol Toxicol; 2014 Sep; 15():47. PubMed ID: 25186061
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.
Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M
Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2012 Jan; 69(1):57-64. PubMed ID: 21603868
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of rectocolic and gastric adenocarcinomas with 5-fluorouracil associated with high doses of folinic acid. Results of an experimental study].
Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Delouche C; Brochon D; Fraioli JP; Jasmin C; Maral R; Mathe G
Sem Hop; 1982 Sep; 58(33):1873-5. PubMed ID: 6293063
[TBL] [Abstract][Full Text] [Related]
16. [Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment].
Kitamura M; Arai K; Miyashita K; Kosaki G
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2936-9. PubMed ID: 2506831
[TBL] [Abstract][Full Text] [Related]
17. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
18. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).
Nishina T; Boku N; Gotoh M; Shimada Y; Hamamoto Y; Yasui H; Yamaguchi K; Kawai H; Nakayama N; Amagai K; Mizusawa J; Nakamura K; Shirao K; Ohtsu A;
Gastric Cancer; 2016 Jul; 19(3):902-10. PubMed ID: 26386560
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of 5-fluorouracil, leucovorin and levamisole.
Cleary JF; Arzoomanian R; Alberti D; Feierabend C; Storer B; Witt P; Carbone P; Wilding G
Cancer Chemother Pharmacol; 1997; 39(4):300-6. PubMed ID: 9025770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
